BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28129624)

  • 21. Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.
    Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Ando T; Ito H; Hatano Y; Tomita H; Kuno T; Saito K; Seishima M; Hara A
    Cancer Sci; 2015 Aug; 106(8):1008-15. PubMed ID: 26033215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis.
    Dong H; Wang M; Chang C; Sun M; Yang F; Li L; Feng M; Zhang L; Li Q; Zhu Y; Qiao Y; Xie T; Chen J
    Biochem Pharmacol; 2020 Dec; 182():114266. PubMed ID: 33035506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
    Lemos H; Mohamed E; Huang L; Ou R; Pacholczyk G; Arbab AS; Munn D; Mellor AL
    Cancer Res; 2016 Apr; 76(8):2076-81. PubMed ID: 26964621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erianin suppresses proliferation and migration of cancer cells in a pyruvate carboxylase-dependent manner.
    Hong J; Xie Z; Yang F; Jiang L; Jian T; Wang S; Guo Y; Huang X
    Fitoterapia; 2022 Mar; 157():105136. PubMed ID: 35093481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of metabotropic glutamate receptor 1 suppresses tumor growth and angiogenesis in experimental non-small cell lung cancer.
    Xia H; Zhao YN; Yu CH; Zhao YL; Liu Y
    Eur J Pharmacol; 2016 Jul; 783():103-11. PubMed ID: 27132814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer.
    Huang TT; Yen MC; Lin CC; Weng TY; Chen YL; Lin CM; Lai MD
    Cancer Sci; 2011 Dec; 102(12):2214-20. PubMed ID: 21899659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogrammed IDO-Induced Immunosuppressive Microenvironment Synergizes with Immunogenic Magnetothermodynamics for Improved Cancer Therapy.
    Wang X; Yan B; Li H; Yuan J; Guo J; Wang S; Dai P; Liu X
    ACS Appl Mater Interfaces; 2024 Jun; 16(24):30671-30684. PubMed ID: 38843203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IDO is a nodal pathogenic driver of lung cancer and metastasis development.
    Smith C; Chang MY; Parker KH; Beury DW; DuHadaway JB; Flick HE; Boulden J; Sutanto-Ward E; Soler AP; Laury-Kleintop LD; Mandik-Nayak L; Metz R; Ostrand-Rosenberg S; Prendergast GC; Muller AJ
    Cancer Discov; 2012 Aug; 2(8):722-35. PubMed ID: 22822050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
    Murakami Y; Hoshi M; Hara A; Takemura M; Arioka Y; Yamamoto Y; Matsunami H; Funato T; Seishima M; Saito K
    Cytokine; 2012 Aug; 59(2):245-51. PubMed ID: 22609210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
    Yoshida N; Ino K; Ishida Y; Kajiyama H; Yamamoto E; Shibata K; Terauchi M; Nawa A; Akimoto H; Takikawa O; Isobe K; Kikkawa F
    Clin Cancer Res; 2008 Nov; 14(22):7251-9. PubMed ID: 19010841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition.
    Pan J; Yuan K; Peng S; Huang Y; Zhang Y; Hu Y; Feng Y; Shi Y; Liu Y; Wang H; Zhou N; Min W
    Int J Oncol; 2017 Jun; 50(6):2136-2144. PubMed ID: 28498425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway.
    Wang D; Saga Y; Sato N; Nakamura T; Takikawa O; Mizukami H; Matsubara S; Fujiwara H
    Int J Oncol; 2016 Jun; 48(6):2303-9. PubMed ID: 27082119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
    Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
    PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erianin Controls Collagen-Mediated Retinal Angiogenesis via the RhoA/ROCK1 Signaling Pathway Induced by the alpha2/beta1 Integrin-Collagen Interaction.
    Li X; Liu X; Xing Y; Zeng L; Liu X; Shen H; Ma J
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):27. PubMed ID: 35060996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salmonella overcomes tumor immune tolerance by inhibition of tumor indoleamine 2, 3-dioxygenase 1 expression.
    Kuan YD; Lee CH
    Oncotarget; 2016 Jan; 7(1):374-85. PubMed ID: 26517244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma.
    Asghar K; Farooq A; Zulfiqar B; Rashid MU
    World J Gastroenterol; 2017 Apr; 23(13):2286-2293. PubMed ID: 28428708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.